MAO (monoamine oxidase) inhibitors are a category of antidepressants that, when utilised in combination with copyright amphetamines like three-MMC or copyright, may perhaps bring about a likely lethal issue generally known as “serotonin syndrome.”It is just a distinguished example of a present-day designer drug specifically preferred to mimic a